Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

PRIVATE SALE OF EPILLO TOKEN TO GO LIVE ON 3O OCTOBER, 2022 AT 12 PM GMT


News provided by

Epillo Health Systems

27 Oct, 2022, 16:28 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, Oct. 27, 2022 /PRNewswire/ -- Epillo Health Systems OÜ is a company focused on consumer health and fitness solutions, founded in 2020. Through the implementation of blockchain technology, IoT, artificial intelligence and Web 3.0, the Epillo Health group aims to reduce the healthcare barriers and provide quality care, increase efficiency and access to care, and improve patient satisfaction to redefine the next era of healthcare and blockchain industry.

Continue Reading
This image opens in the lightbox
PRIVATE SALE OF EPILLO TOKEN TO GO LIVE ON 3O OCTOBER, 2022 AT 12 PM GMT

On October 30th 2022, the company will offer an exclusive early bird sale of the EPILLO token. This is an opportunity to enter the diverse and futuristic Epillo ecosystem and contribute to their future developments at a staggering discounted price.

Soon after the formation, the company set-up its medical research wing and conducted its research on Blockchain based drug-drug interactions and drug-food interactions to reduce the adverse drug effects (ADEs) arising in the society due to multiplicity of drugs and food items being consumed in daily life. After conducting its research, in January 2021, the company filed a Patent of its technology – A Digital Therapeutics software based out of "System And Method for Blockchain Based Digital Therapeutic Devices To Predict Food-Drug Constituent Interaction". This technology assists in providing a drug interaction management tool with respect to drug-dietary interactions to help curbing ADEs, less effective medication & low drug-adherence rates. On 23.06.2022, the patent filed by the company received its initial publication vide publication no. WO 2022/132205 and was gazetted by the World Intellectual Property Organisation. On 12.03.2021, Sagacious IP, an International Consultancy, specializing in the Intellectual Property spectrum and valuations of companies, appraised the patent at a valuation of $ 150 million. Now, since the patent received its first publication from WIPO in June 2022, the valuation is expected to go up to $ 250 million in the running quarter.

Further, Epillo HealthHUB - Asia's first health, medicine and nutrition retail center was established in April 2022. This retail center offers a unique combination of a Pharmacy, Doctor Consultation, Lab Testing including detailed Genomic testing, over the counter health, fitness & wellness products along with a in-house Health-food brand, namely Freshwey. This health, medicine and nutrition wellness centre stores all the data in the form of Electronic Health Records through the mobile application – Epillo Health Mate. The HealthHUB also provides its users to avail online doctor consultation services from their home.

While the sister concern company was establishing this 'all of healthcare under one roof' center, Epillo Health Systems OÜ, began its research and development in the spectrum of blockchain based Internet of Things (IoT) in August 2022. Epillo.io was formed to represent the Blockchain vertical of Epillo Health Systems wherein the cutting-edge blockchain technology has been harnessed to develop a disruptive IoT wearable range – Fitmint Wear. The company embarked this journey through a first-of-its-kind blockchain based smartwatch - Fitmint Wear Pro coupled with the companion decentralized mobile application with features like NFT authentication, storing health data on chain, decentralized finance, NFT marketplace, health and fitness product marketplace, staking and swapping platform.

The company aims to govern this entire Epillo ecosystem through their project token – EPILLO, wherever permissible.

ABOUT THE TOKEN

Epillo Health Token (EPILLO) is the native token of Epillo Health Systems. Developed using next generation smart contract standard ERC-1155, the token will be deployed on the Polygon smart chain, an Ethereum scaling blockchain. By the end of the year, the company expects the EPILLO token to be available on multiple centralized and decentralized exchanges. Additionally,  the token will also be available for customers of the Fitmint Wear, a next generation wearable device from which users will be able to mint the token as an incentivisation mechanism to become more physically active. The total supply of the token is capped at 5 billion.

UTILITIES

As previously mentioned, one of the biggest use cases the token will have is to incentivise users of the Fitmint Wear to become more physically active through the gamification of workouts. Through this mechanism, the more calories you burn, the more EPILLO you will generate. However, this is not the only intended use for the token.  The goal of the token is to create a sustainable economy by offering multiple utilities in the entire Epillo Ecosystem (consumer healthcare, health-tech and digital health, health food and beverages, and blockchain health and fitness). EPILLO will have multiple uses, including but not limited to:

  • Purchase and powering of the Web 3.0 smartwatch.
  • Availing global health consultation and digital health services.
  • Access to gameplay in Fitmint Wear.
  • Gene/DNA testing.
  • Health and fitness e-commerce marketplace.
  • Minting NFTs and access to NFT marketplace.
  • Staking and swapping.
  • Redemption against health-food offerings.
  • Medical fundraising in the research projects.
  • Investments in retail health stores and much more!

THE GOLDEN OPPORTUNITY: PRE-SALE

With an established base in the Healthcare industry for building an entire ecosystem through state of the art technologies in the best industries, the Epillo Health Token (EPILLO) has the potential to be the "Bitcoin of the healthcare" and fitness industry. The first pre-sale of the EPILLO token will begin on "October 30th, 2022 at 12 PM GMT". For this first stage, the company expects to sell 10% of the total supply at a discounted price of $ 0.55 i.e., at a staggering discount of 33% from its premium price. Furthermore, for the benefit of the community and the investors, the EPILLO coins sold during the private sale will have a two months vesting period and the remaining will be released to the wallets 25 % each month thereafter, once this period expires. Once the private and public sale finishes, the company will initiate the listing on exchanges in December 2022 and simultaneously the Token Generation Event will take place.

To stay in touch with all the updates, please visit www.epillo.io
To get whitelisted & participate in the private sale, please visit www.epillo.io/defi 

For further queries, please contact on info@epillo.io

Photo: https://mma.prnewswire.com/media/1931720/Epillo_Token_Sale.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.